Ignite Creation Date:
2024-05-05 @ 11:44 AM
Last Modification Date:
2024-10-26 @ 9:12 AM
Study NCT ID:
NCT00110825
Status:
COMPLETED
Last Update Posted:
2017-01-12
First Post:
2005-05-13
Brief Title:
Behavioral Smoking Cessation Treatment - 1
Sponsor:
National Institute on Drug Abuse NIDA
Organization:
National Institute on Drug Abuse NIDA
Study Overview
Official Title:
Behavioral Maintenance Treatment for Smoking Cessation
Status:
COMPLETED
Status Verified Date:
2009-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Our primary goal is to examine the effectiveness of a multi-factor maintenance treatment strategy in promoting longer-term smoking abstinence We will also conduct secondary analyses of mediators and moderators of treatment response
Detailed Description:
400 adult smokers will be randomized Our primary goal is to examine the effectiveness of a multi-factor maintenance treatment strategy in promoting longer-term smoking abstinence All smokers will receive the same Acute Phase Treatment that combines nicotine patch bupropion and intensive self-regulatory skills training Nicotine patches will be provided for 8 weeks and bupropion and skills training will be provided for of 9 weeks Participants will then enter a Maintenance Treatment Phase during which half n200 will receive three individualized relapse prevention training sessions spread over a 12 week period They will also receive 12 weeks of self-administered RPT administered via written treatment modules Finally telephone counseling will be provided in conjunction with an Interactive Voice Response system IVR that will allow early detection of smoking slips and rapid response by treatment staff The other half n200 will be assigned to a control condition that consists of three counselor-led sessions of supportive therapy spread over a 12 week period P
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| DPMCDA | None | None | None |
| R01-DA17441-1 | None | None | None |